The Department of Health and Human Services, specifically the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC), are seeking proposals for Small Business Innovation Research (SBIR) contracts. The solicitation, titled "Evaluation Datasets as Medical Device Development Tools for Testing Cancer Technologies," aims to address the need for large, well-curated datasets that can be used to evaluate cancer medical devices subject to regulation by the Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA). The goal is to develop datasets that can measure device effectiveness or performance and support regulatory decision-making. The solicitation emphasizes the importance of reducing the regulatory burden on industry and the FDA. The funding for this project is as follows: Phase I proposals can receive up to $400,000 for a duration of up to 12 months, while Phase II proposals can receive up to $2,000,000 for a duration of up to 2 years. The solicitation is closed, and the anticipated number of awards is 3-5. For more information, refer to the solicitation link.